Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
HIV-derived lentiviral vectors are efficient vehicula to deliver genes into the brain and hold great promise for future gene therapy of neurodegenerative disorders. However, administration of the current vector preparations in mouse brain was found to induce a systemic immune response to vector proteins and a modest inflammation in the brain. Moreover, serum antibodies from vector-treated animals were capable of partially neutralizing lentiviral vector-mediated transduction in cell culture. To avoid this unexpected immune reaction, we have optimized new vector production and purification protocols. Purification by sucrose gradient ultracentrifugation abolished the immune response, but vector titers also decreased substantially. Lentiviral vector production in the absence of serum in the cell culture medium equally reduced immunogenicity without affecting transduction efficiency. These results have important implications for future clinical use of lentiviral vectors, and for the use of lentiviral vectors to create animal models for neurodegenerative diseases that have an important neuroinflammatory component.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The purity of the product is critical; debris from the packaging cells can easily be collected along with the vector product, and these impurities may cause inflammatory responses in vitro and in vivo [64].”
From Clinical use of lentiviral vectors (2018) · cites this paper as [64]
Citations
Cites
Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.-Y., Palfi, S., Roitberg, B. Z., et al. (2000) · Science · doi:10.1126/science.290.5492.767 · Cited by 1,251
Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
Blömer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., & Gage, F. H. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6641-6649.1997 · Cited by 725
Cellular Proteins Bound to Immunodeficiency Viruses: Implications for Pathogenesis and Vaccines
Arthur, L. O., Bess, J. W., Sowder, R. C., Benveniste, R. E., Mann, D. L., Chermann, J.-C., & Henderson, L. E. (1992) · Science · doi:10.1126/science.1470916 · Cited by 559
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Mazarakis, N. D. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2109 · Cited by 426
Dewey, R. A., Morrissey, G., Cowsill, C. M., Stone, D., Bolognani, F., Dodd, N. J. F., Southgate, T. D., Klatzmann, D., Lassmann, H., Castro, M. G., et al. (1999) · Nature Medicine · doi:10.1038/15207 · Cited by 311
Selvaggi, T. A., Walker, R. E., & Fleisher, T. A. (1997) · Blood · doi:10.1182/blood.v89.3.776 · Cited by 272
Thomas, C. E., Schiedner, G., Kochanek, S., Castro, M. G., & Löwenstein, P. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120474397 · Cited by 253
Follenzi, A., Sabatino, G., Lombardo, A., Boccaccio, C., & Naldini, L. (2002) · Human Gene Therapy · doi:10.1089/10430340252769770 · Cited by 244
VSV-G Pseudotyped Lentiviral Vector Particles Produced in Human Cells Are Inactivated by Human Serum
DePolo, N. J., Reed, J. D., Sheridan, P. L., Townsend, K., Sauter, S. L., Jolly, D. J., & Dubensky, T. W. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0116 · Cited by 220
Cited by
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Clinical use of lentiviral vectors
Milone, M. C., & O’Doherty, U. (2018) · Leukemia · doi:10.1038/s41375-018-0106-0 · Cited by 930
“The purity of the product is critical; debris from the packaging cells can easily be collected along with the vector product, and these impurities may cause inflammatory responses in vitro and in vivo [64].”
BackgroundProduction, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
Kutner, R. H., Zhang, X.-Y., & Reiser, J. (2009) · Nature Protocols · doi:10.1038/nprot.2009.22 · Cited by 668
Altering the Tropism of Lentiviral Vectors through Pseudotyping
Cronin, J., Zhang, X.-Y., & Reiser, J. (2005) · Current Gene Therapy · doi:10.2174/1566523054546224 · Cited by 536
Gene delivery by lentivirus vectors
Cockrell, A. S., & Kafri, T. (2007) · Molecular Biotechnology · doi:10.1007/s12033-007-0010-8 · Cited by 355
Metadata
- Authors
- Baekelandt, V, Eggermont, K., Michiels, M., Nuttin, B., & Debyser, Z.
- Affiliations
- KU Leuven (BE)
- Rega Institute for Medical Research (BE)
- Venue
- Gene Therapy
- Published
- 2003-10-06
- Volume
- 10
- Issue
- 23
- Pages
- 1933-1940
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2093474070
- Cited by
- 153
- References
- 24
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 7 · 2019: 9 · 2018: 2 · 2017: 5 · 2016: 10 · 2015: 8 · 2014: 3 · 2013: 5 · 2012: 9
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- lentiviral vectors, vector purification, immunogenicity, immune response, sucrose gradient ultracentrifugation, serum-free medium, neutralizing antibodies, neuroinflammation, animal models of neurodegenerative disease
- MeSH terms
- Animals, Antibodies, Brain, Female, Genetic Vectors, Injections, Intraventricular, Luminescent Proteins, Male, Mice, Inbred C57BL, Transduction, Genetic, Virus Cultivation, Genetic Therapy, HIV-1, Gene Expression, Culture Media, Serum-Free, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain. https://app.cochat.ai/papers/10.1038/sj.gt.3302094
- The paper
- Baekelandt, V, Eggermont, K., Michiels, M., Nuttin, B., & Debyser, Z. (2003). Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain. Gene Therapy. https://doi.org/10.1038/sj.gt.3302094
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.